Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyHematologic NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideStem Cell TransplantationMultiple MyelomaGraft vs Host DiseaseHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationTreatment OutcomeGraft SurvivalLymphoma, Non-HodgkinStem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceIfosfamideCarmustineCord Blood Stem Cell TransplantationSalvage TherapyCytophagocytosisHematopoiesisVincristineDisease-Free SurvivalCytarabineAmyloidosisHodgkin DiseaseTissue DonorsTransplantation ChimeraSurvival RateNeoplasmsRetrospective StudiesWhole-Body IrradiationSurvival AnalysisDoxorubicinInfectionBlood Cell CountHistocompatibilityTime FactorsBlood CellsPlatelet CountPOEMS SyndromeHistocompatibility TestingCarboplatinLymphoma, T-CellVidarabineImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicBone Marrow PurgingRecombinant ProteinsLeukemiaAntineoplastic AgentsPrednisoneDexamethasoneFollow-Up StudiesLymphomaFeasibility StudiesProspective StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectFatal OutcomeImmunophenotypingBlood DonorsLeukocytes, MononuclearAnemia, AplasticMyelodysplastic SyndromesBone MarrowLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCell SeparationHematologic DiseasesBreast NeoplasmsT-LymphocytesHistiocytosis, Non-Langerhans-CellFlow CytometryEmbryonic Stem CellsBone Marrow DiseasesPrognosisImmunomagnetic SeparationPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsLeukocyte CountCyclosporineLivedo Reticularis